Ascendis Pharma A (ASND) Tax Rate Growth (1y) (2015 - 2026)

Ascendis Pharma A (ASND) Tax Rate Growth (1y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Ascendis Pharma A 15.35 Bn 14.68 Bn 268.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 140,517.00
Dec 31, 2025 2,277.00
Sep 30, 2025 527.00
Jun 30, 2025 1,078.00
Mar 31, 2025 -82.00
Dec 31, 2024 -424.00
Sep 30, 2024 64.00
Jun 30, 2024 56.00
Mar 31, 2024 77.00
Dec 31, 2023 450.00
Sep 30, 2023 50.00
Jun 30, 2023 -29.00
Mar 31, 2023 99.00
Dec 31, 2022 254.00
Sep 30, 2022 -9.00
Jun 30, 2022 -11.00
Mar 31, 2022 -11.00
Dec 31, 2021 10.00
Sep 30, 2021 -2.00
Jun 30, 2021 -6.00